The Australian Privacy Guide for AI Medical Scribes
Using an AI medical scribe means a third-party system is capturing, processing and often storing sensitive patient health information, often verbatim from a live consultation. That puts AI scribes squarely inside the Privacy Act 1988 and the Australian Privacy Principles (APPs).
Not legal advice. This guide is general information based on publicly available regulatory guidance, not legal advice — confirm current obligations with your own legal counsel or the OAIC before relying on any specific compliance claim, including any vendor's own claims (including MedTalk AI's).
Why This Matters More for AI Scribes Than Most Practice Software
An AI scribe actively listens to and processes a live conversation — collecting new sensitive information in real time — which makes consent, purpose limitation and data handling more actively relevant than for a passive record-keeping system.
The Australian Privacy Principles That Matter Most
Open and transparent management
A clear, up-to-date privacy policy disclosing AI tool use and what it processes.
Collection of solicited information
Informed patient consent is generally required to collect sensitive health information — including the recording itself.
Use or disclosure
Use limited to the purpose collected for; no repurposing (e.g. model training) without separate, specific consent.
Cross-border disclosure
If any processing happens offshore, the practice must ensure APP-consistent handling or obtain express patient consent.
Security of personal information
Reasonable security steps, relevant to encryption and raw-audio retention.
What "Informed" Actually Requires
At minimum, the patient should be:
- Told the session is recorded/processed by AI
- Broadly what the tool does with it
- Whether the recording is retained or destroyed
- Where data is processed, if material
A vague "this session may be recorded" notice likely doesn't meet the bar. Best practice is a consent step built into the clinical workflow, prompted before each recording.
The December 2026 Automated Decision-Making Disclosure Requirement
From 10 December 2026, practices must disclose in their privacy policy whether they use automated decision-making systems that could significantly affect individuals.
Whether a given AI scribe implementation is in scope depends on exactly what it does — don't assume it's automatically out of scope; get a specific legal review ahead of the deadline.
Data Residency: Why It's a First-Order Question
Data residency determines whether APP 8 is triggered, and is a proxy for how seriously a vendor has considered AU regulatory requirements.
A vendor confirming 100% AU data residency (e.g. AWS/Azure Sydney/Melbourne) removes an entire category of cross-border risk.
See MedTalk AI's Australian data residency documentation →A Practical Compliance Checklist
Update your privacy policy to disclose AI scribe use and (from Dec 2026) automated decision-making status
Confirm in writing exactly where data is stored/processed and any offshore subprocessors
Build a specific per-recording consent step
Confirm retention/destruction policy for raw audio
Confirm mandatory clinician review before finalising notes
Review what happens to historical data if you switch vendors
What to Ask a Vendor Directly
Which countries is data stored/processed in, including subprocessors?
What happens to raw audio after note generation?
Is any data used to train models, and can we opt out?
Can you provide documentation for our own privacy policy/procurement review?
See how MedTalk AI approaches these obligations
100% Australian data residency, per-recording consent prompts, and mandatory clinician review before any note is finalised.
Common Questions
Is using an AI medical scribe legal in Australia?
Yes, provided the practice meets its Privacy Act/APP obligations — consent, data handling, transparency.
Do I need separate consent for each session?
There's no universal answer — best practice is a clear, specific consent step per recording; confirm with legal advice.
What if my vendor processes data overseas?
Under APP 8, the practice must ensure APP-consistent handling or obtain express patient consent — this is a practice-level obligation.
Does the December 2026 ADM disclosure requirement apply to AI scribes?
It may, depending on what the tool does — get a specific legal review ahead of the deadline.
Is this article legal advice?
No — general information as of July 2026; confirm current obligations with legal counsel or the OAIC.
Not legal advice. This guide is general information based on publicly available regulatory guidance, not legal advice — confirm current obligations with your own legal counsel or the OAIC before relying on any specific compliance claim, including any vendor's own claims (including MedTalk AI's).
Streamline your clinical notes
with MedTalk AI
Intelligent medical scribe
Get A Free Trial